Registration statement for securities of certain foreign private issuers

Disclosure of New IFRS in the Period (Tables)

v3.19.3.a.u2
Disclosure of New IFRS in the Period (Tables)
 12 Months Ended
Dec. 31, 2018
Disclourse of New IFRS in the Period [Abstract]  
Schedule of consolidated financial statements
  As of January 1, 2018  
    As reported
(IFRS 15)		     Adjustments     IAS 18 (excluding
impact of
IFRS 15)		  
Current liabilities                        
Deferred revenues   $ 280     $ 50     $ 330  
                         
Non - current liabilities                        
Deferred revenues   $ 1,246     $ (400 )   $ 846  
                         
Equity attributable to equity holders of the Company                        
Accumulated deficit   $ (94,052 )   $ 350     $ (93,702 )

 

    As of December 31, 2018  
    As reported
(IFRS 15)		     Adjustments     IAS 18 (excluding
impact of
IFRS 15)		  
Current liabilities                        
Deferred revenues   $ 926     $ (26 )   $ 900  
                         
Non - current liabilities                        
Deferred revenues   $ 1,818     $ (588 )   $ 1,230  
                         
Equity attributable to equity holders of the Company                        
Accumulated deficit   $ (94,052 )   $ 350     $ (93,702 )

 

    Year ended December 31, 2018  
    As reported
(IFRS 15)		     Adjustments     IAS 18 (excluding
impact of
IFRS 15)		  
Revenues   $ 3,820     $ (201 )   $ 3,619  
Operating expenses     (9,234 )     -       (9,234 )
Operating loss     (5,414 )     (201 )     (5,615 )
Financial expense, net     (1,153 )     426       (727 )
Loss before taxes on income   $ (6,567 )   $ 225     $ (6,342 )
Taxes on income     (4 )     -       (4 )
Net loss     (6,571 )             (6,346 )
      .                  
Basic and diluted net loss per share   $ 0.08     $ -     $ 0.08